Skip to main content

Therapy Areas c
- Therapy Areas
- Iron Deficiency
- Dialysis
- Nephrology and Rare Diseases
Ongoing Phase IV Research c
- Ongoing Phase IV Research
- Nephrology and Rare Diseases
Congresses and Events
Medical Requests c
- Medical Requests
- Medical Information Request
- Adverse Event Reporting
- Product Quality Complaint Report
Search

Help us guide you to the right place:

I reside in the United States

Visit the US site

I do not reside in the United States

I am a healthcare professional

This is me, continue

I am not a healthcare professional

This is me, continue

Help us guide you to the right place:

I am a healthcare professional

This is me, continue Icon

I am practicing from:

You are viewing a website from Vifor Pharma. All materials and content available on the website are of strictly non-promotional nature and only intended for healthcare professionals (HCPs) practicing in Europe. By checking the box, you acknowledge that you are a HCP practicing in Europe. Otherwise, please leave the website. Kindly note that materials and content are not intended for any specific country and approval conditions for products may vary from country to country. Before prescribing any product, always refer to the approved label in the relevant country and/or the Summary of Product Characteristics.

Back to options Continue to website

Home THERAPY AREAS

AAV Disease awareness MoD video

30 June 2022
Nephrology and Rare Diseases
ANCA-associated vasculitis

See how the interaction between neutrophils and the alternative complement system are at the heart of the vasculitis process in AAV.

Other articles you might be interested in

July 07, 2022
ANCA-associated vasculitis

The science of complement antagonism in ANCA vasculitis – current understanding

Explore the science

June 30, 2022
ANCA-associated vasculitis

Avacopan as first-line treatment in antineutrophil cytoplasmic antibody-associated vasculitis: A steroid-sparing option

Explore the science

June 30, 2022
ANCA-associated vasculitis

Compassionate use of Avacopan in difficult-to-treat ANCA-associated vasculitis

Explore the science

Address

Vifor Pharma Management Ltd.

Flughofstrasse 61
P.O. Box
8152 Glattbrugg
Switzerland

Stay in touch

Keep up to date on social media or contact us with any other information

+41 58 851 80 00

+41 58 851 80 00

Quick Links

Therapy Areas
Ongoing Phase IV Research
Congresses and Events
Medical Information Request

Terms of Use
Privacy Policy
Cookie Policy
Cookie Preferences

You are now leaving our website and heading to a third-party website that we do not operate. We are not responsible for the content of the third-party website. You are advised to review its privacy policy as it may differ from ours.

Are you sure you want to leave?

Cancel Confirm